SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BofA Raises UCB Price Target and EPS Forecasts After FY26 Guidance Increase

Bank of America raised its price target and EPS forecasts for UCB after the company increased its fiscal 2026 guidance. The report attributes the updated outlook to strong performance by two primary pharmaceutical products.

UCB

Related stories